These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37891178)

  • 1. Standardized Brazilian green propolis extract (EPP-AF®) in COVID-19 outcomes: a randomized double-blind placebo-controlled trial.
    Silveira MAD; Menezes MA; de Souza SP; Galvão EBDS; Berretta AA; Caldas J; Teixeira MB; Gomes MMD; Damiani LP; Bahiense BA; Cabral JB; De Oliveira CWLM; Mascarenhas TR; Pinheiro PCG; Alves MS; de Melo RMV; Leite FM; Nonaka CKV; Souza BSF; Baptista NU; Teles F; da Guarda SF; Mendes AVA; Passos RDH
    Sci Rep; 2023 Oct; 13(1):18405. PubMed ID: 37891178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Brazilian green propolis (EPP-AF®) as an adjunct treatment for hospitalized COVID-19 patients: A randomized, controlled clinical trial.
    Silveira MAD; De Jong D; Berretta AA; Galvão EBDS; Ribeiro JC; Cerqueira-Silva T; Amorim TC; Conceição LFMRD; Gomes MMD; Teixeira MB; Souza SP; Santos MHCAD; San Martin RLA; Silva MO; Lírio M; Moreno L; Sampaio JCM; Mendonça R; Ultchak SS; Amorim FS; Ramos JGR; Batista PBP; Guarda SNFD; Mendes AVA; Passos RDH;
    Biomed Pharmacother; 2021 Jun; 138():111526. PubMed ID: 34311528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of standardized Brazilian green propolis extract (EPP-AF) as an adjunct treatment for hospitalized COVID-19 patients (BeeCovid2): a structured summary of a study protocol for a randomized controlled trial.
    Silveira MAD; de Souza SP; Dos Santos Galvão EB; Teixeira MB; Gomes MMD; Damiani LP; Bahiense BA; Cabral JB; De Oliveira CWLM; Mascarenhas TR; Pinheiro PCG; Alves MS; de Melo RMV; Berretta AA; Leite FM; Nonaka CKV; de Freitas Souza BS; Mendes AVA; da Guarda SF; da Hora Passos R
    Trials; 2022 Apr; 23(1):255. PubMed ID: 35379306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of propolis supplementation on clinical symptoms in patients with coronavirus (COVID-19): A structured summary of a study protocol for a randomised controlled trial.
    Miryan M; Soleimani D; Dehghani L; Sohrabi K; Khorvash F; Bagherniya M; Sayedi SM; Askari G
    Trials; 2020 Dec; 21(1):996. PubMed ID: 33272309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of Brazilian Green Propolis extract on inflammation in patients with chronic kidney disease on peritoneal dialysis: A randomised double-blind controlled clinical trial.
    Baptista BG; Fanton S; Ribeiro M; Cardozo LF; Regis B; Alvarenga L; Ribeiro-Alves M; Berretta AA; Shiels PG; Mafra D
    Phytomedicine; 2023 Jun; 114():154731. PubMed ID: 36934668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Standardized Brazilian Green Propolis Extract (EPP-AF®) on Inflammation in Haemodialysis Patients: A Clinical Trial.
    Duarte Silveira MA; Malta-Santos H; Rebouças-Silva J; Teles F; Batista Dos Santos Galvão E; Pinto de Souza S; Dantas Dutra FR; Dantas Gomes MM; Teixeira MB; Miranda Rebelo da Conceição LF; Nascimento CS; Vasques Nonaka CK; Cezar RS; Pena Batista PB; Berretta AA; Borges VM; da Hora Passos R
    Int J Nephrol; 2022; 2022():1035475. PubMed ID: 36457860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leishmanicidal and immunomodulatory properties of Brazilian green propolis extract (EPP-AF
    Rebouças-Silva J; Amorim NA; Jesus-Santos FH; de Lima JA; Lima JB; Berretta AA; Borges VM
    Front Pharmacol; 2023; 14():1013376. PubMed ID: 36843932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of propolis on inflammation markers in patients undergoing hemodialysis: A randomized, double-blind controlled clinical trial.
    Chermut TR; Fonseca L; Figueiredo N; de Oliveira Leal V; Borges NA; Cardozo LF; Correa Leite PE; Alvarenga L; Regis B; Delgado A; Berretta AA; Ribeiro-Alves M; Mafra D
    Complement Ther Clin Pract; 2023 May; 51():101732. PubMed ID: 36708650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of propolis plus Hyoscyamus niger L. against COVID-19: A phase II, multicenter, placebo-controlled, randomized trial.
    Kosari M; Khorvash F; Sayyah MK; Ansari Chaharsoughi M; Najafi A; Momen-Heravi M; Karimian M; Akbari H; Noureddini M; Salami M; Ghaderi A; Amini Mahabadi J; Khamechi SP; Yeganeh S; Banafshe HR
    Phytother Res; 2024 Jan; 38(1):400-410. PubMed ID: 37992760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): a structured summary of a study protocol for a randomized controlled trial.
    Vallejos J; Zoni R; Bangher M; Villamandos S; Bobadilla A; Plano F; Campias C; Chaparro Campias E; Achinelli F; Guglielmone HA; Ojeda J; Medina F; Farizano Salazar D; Andino G; Ruiz Diaz NE; Kawerin P; Meza E; Dellamea S; Aquino A; Flores V; Martemucci CN; Vernengo MM; Martinez SM; Segovia JE; Aguirre MG
    Trials; 2020 Nov; 21(1):965. PubMed ID: 33234158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twice-Daily Oral Zinc in the Treatment of Patients With Coronavirus Disease 2019: A Randomized Double-Blind Controlled Trial.
    Ben Abdallah S; Mhalla Y; Trabelsi I; Sekma A; Youssef R; Bel Haj Ali K; Ben Soltane H; Yacoubi H; Msolli MA; Stambouli N; Beltaief K; Grissa MH; Khrouf M; Mezgar Z; Loussaief C; Bouida W; Razgallah R; Hezbri K; Belguith A; Belkacem N; Dridi Z; Boubaker H; Boukef R; Nouira S
    Clin Infect Dis; 2023 Jan; 76(2):185-191. PubMed ID: 36367144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of COVID-19 pneumonia with glucocorticoids (CORTIVID): a structured summary of a study protocol for a randomised controlled trial.
    Les Bujanda I; Loureiro-Amigo J; Bastons FC; Guerra IE; Sánchez JA; Murgadella-Sancho A; Rey RG; López JL; Álvarez JS
    Trials; 2021 Jan; 22(1):43. PubMed ID: 33430891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
    Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
    Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial.
    Murai IH; Fernandes AL; Sales LP; Pinto AJ; Goessler KF; Duran CSC; Silva CBR; Franco AS; Macedo MB; Dalmolin HHH; Baggio J; Balbi GGM; Reis BZ; Antonangelo L; Caparbo VF; Gualano B; Pereira RMR
    JAMA; 2021 Mar; 325(11):1053-1060. PubMed ID: 33595634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A standardized polyphenol mixture extracted from poplar-type propolis for remission of symptoms of uncomplicated upper respiratory tract infection (URTI): A monocentric, randomized, double-blind, placebo-controlled clinical trial.
    Esposito C; Garzarella EU; Bocchino B; D'Avino M; Caruso G; Buonomo AR; Sacchi R; Galeotti F; Tenore GC; Zaccaria V; Daglia M
    Phytomedicine; 2021 Jan; 80():153368. PubMed ID: 33091857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.
    Palacios R; Patiño EG; de Oliveira Piorelli R; Conde MTRP; Batista AP; Zeng G; Xin Q; Kallas EG; Flores J; Ockenhouse CF; Gast C
    Trials; 2020 Oct; 21(1):853. PubMed ID: 33059771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.